These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35154153)

  • 1. Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.
    Jiang P; Nolte IM; Hepkema BG; Stulp M; van den Berg A; Diepstra A
    Front Immunol; 2022; 13():829943. PubMed ID: 35154153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
    Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
    Blood; 2011 Nov; 118(19):5211-7. PubMed ID: 21921049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
    La Nasa G; Greco M; Littera R; Oppi S; Celeghini I; Caria R; Lai S; Porcella R; Martino M; Romano A; Di Raimondo F; Gallamini A; Carcassi C; Caocci G
    J Hematol Oncol; 2016 Mar; 9():26. PubMed ID: 26983546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma.
    Liu Z; Jarrett RF; Hjalgrim H; Proietti C; Chang ET; Smedby KE; Yu KJ; Lake A; Troy S; McAulay KA; Pfeiffer RM; Adami HO; Glimelius B; Melbye M; Hildesheim A; Doolan DL; Coghill AE
    Int J Cancer; 2020 Aug; 147(3):608-618. PubMed ID: 31618442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
    Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
    PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced frequency of cytotoxic CD56
    Pánisová E; Lünemann A; Bürgler S; Kotur M; Lazarovici J; Danu A; Kaulfuss M; Mietz J; Chijioke O; Münz C; Busson P; Berger C; Ghez D; Azzi T
    Cancer Immunol Immunother; 2022 Jan; 71(1):13-24. PubMed ID: 33993319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA associations in classical Hodgkin lymphoma: EBV status matters.
    Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
    PLoS One; 2012; 7(7):e39986. PubMed ID: 22808081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China.
    Huang X; Hepkema B; Nolte I; Kushekhar K; Jongsma T; Veenstra R; Poppema S; Gao Z; Visser L; Diepstra A; van den Berg A
    PLoS One; 2012; 7(2):e31865. PubMed ID: 22355400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
    Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
    Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
    Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
    Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.
    Asano N; Yamamoto K; Tamaru J; Oyama T; Ishida F; Ohshima K; Yoshino T; Nakamura N; Mori S; Yoshie O; Shimoyama Y; Morishima Y; Kinoshita T; Nakamura S
    Blood; 2009 Mar; 113(12):2629-36. PubMed ID: 19075188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.
    Sarathkumara YD; Xian RR; Liu Z; Yu KJ; Chan JKC; Kwong YL; Lam TH; Liang R; Chiu B; Xu J; Hu W; Ji BT; Coghill AE; Kelly AM; Pfeiffer RM; Rothman N; Ambinder RF; Hildesheim A; Lan Q; Proietti C; Doolan DL
    Int J Cancer; 2024 Oct; 155(8):1476-1486. PubMed ID: 38995124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
    Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
    Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.
    Assis MC; Campos AH; Oliveira JS; Soares FA; Silva JM; Silva PB; Penna AD; Souza EM; Baiocchi OC
    Med Oncol; 2012 Dec; 29(5):3614-9. PubMed ID: 22791223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
    PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients.
    Huang X; van den Berg A; Gao Z; Visser L; Nolte I; Vos H; Hepkema B; Kooistra W; Poppema S; Diepstra A
    PLoS One; 2010 May; 5(5):e10865. PubMed ID: 20526359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.